**Tim Hulsen**

Tim Hulsen is a bioinformatician and data scientist with a broad experience in both academia and the industry, working on a wide range of oncology projects. After receiving his MSc in biology in 2001, he obtained a PhD in bioinformatics in 2007 from a collaboration between the Radboud University Nijmegen and the pharma company N.V. Organon.

After a two year post-doc at the Radboud University Nijmegen, he moved to Philips Research in 2009, where he worked on biomarker discovery for one year, before moving to the Translational Research IT field, working on big data projects in oncology, such as Prostate Cancer Molecular Medicine (PCMM), Translational Research IT (TraIT), Movember Global Action Plan 3 (GAP3), and the European Randomized Study of Screening for Prostate Cancer (ERSPC).

His current projects are Liquid Biopsies and Imaging (LIMA), which is concerned with the use of Liquid Biopsies and Imaging data in breast cancer and rectal cancer, and ReIMAGINE, which studies the use of imaging to prevent unnecessary biopsies in prostate cancer. He is the author of several publications in the area of big data, data management, precision medicine, and personalized healthcare.
